ESC 365 - Assessing the arrhythmogenic risk associated with pathological mutations in caveolin 3 gene using both heterologous systems and iPSC-cardiomyocytes

EHRA Premium Access

Assessing the arrhythmogenic risk associated with pathological mutations in caveolin 3 gene using both heterologous systems and iPSC-cardiomyocytes

Session: Human iPSC-derived cardiomyocytes in arrhythmia research

Topic: Arrhythmias

Speaker: Doctor P. Benzoni (Milan, IT)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Doctor Patrizia Benzoni

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)

1 presentation

0 follower

4 more presentations in this session

Human iPSC-derived cardiomyocytes in electrophysiology: what are they good for?

Speaker: Doctor T. Christ (Hamburg, DE)

Generation of iPSC from human adult progenitor cells: reprogramming efficiency and cardiac differentiation potential

Speaker: Doctor C. Altomare (Bellinzona, CH)

Human iPSC-derived cardiomyocytes as cell-based platform to study cardiac senescence

Speaker: Doctor A. Lodrini (Leiden, NL)

Chronic high glucose induces Ca2+ mishandling via Epac2 in h-iPSC derived cardiomyocytes

Speaker: Doctor L. Pereira (Chatenay-Malabry, FR)

Access the full session

Human iPSC-derived cardiomyocytes in arrhythmia research

Speakers: Doctor P. Benzoni, Doctor T. Christ, Doctor C. Altomare, Doctor A. Lodrini, Doctor L. Pereira

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources